A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)
Clinical trial NCT05468632 · COMPLETED
Trial details
- NCT number
- NCT05468632
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-05
- Primary completion
- 2022-07-31
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.